leriglitazone

oral PPAR_ agonist for CNS diseases

Ph. II and III ongoing for AMN and cALD

one of the metabolites of pioglitazone

Science Translational Medicine

Minoryx Therapeutics S.L., Barcelona, ES

14. The Minoryx peroxisome proliferator-activated receptor gamma (PPAR_) agonist, leriglitazone, is one of the several metabolites of pioglitazone, a member of the thiazolidinedione (glitazone) drug class for diabetes. It…


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.